Tuttiquotidiani is completely free. Every day we aggregate news from 100+ sources and generate original AI summaries for you. Help us keep the service running with a small donation, or become TQ Pro for just €1/month.

Donate now TQ Pro - 1€/mo
  1. Home

China’s Innovent Biologics signs US$10.5b Pfizer deal for 12 cancer drug trials

  • Posted on May 29, 2026
  • By South China Morning Post
  • 0 Views
  • 1 min read
China’s Innovent Biologics signs US$10.5b Pfizer deal for 12 cancer drug trials
China’s Innovent Biologics signs US$10.5b Pfizer deal for 12 cancer drug trials

The agreement covers eight early-stage trials from Innovent and four discovery programmes from global giant Pfizer.
continue reading...

Author
South China Morning Post

You May Also Like